Funds and prices

Overview

Very actively managed equity fund based on a concentrated equity portfolio investing in selected Chinese companies

The manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.

Diversified across sectors offering broad coverage of the Chinese market

The portfolio manager is not tied to the benchmark in terms of investment selection or weight.

Benefits

Easy access to investment opportunities provided by a rapidly growing Chinese economy. Investors gain access to all classes of shares providing China equity exposure: A, B and H shares as well as Red Chips

Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.

Investors benefit from ÃÛ¶¹ÊÓƵ being one of the few asset managers with a truly global investment platform

The experienced portfolio management team can leverage local investment expertise in the Chinese market via our joint venture ÃÛ¶¹ÊÓƵ SDIC in China

Risks

ÃÛ¶¹ÊÓƵ Opportunity Equity Funds invest in equities and may therefore be subject to high fluctuations in value. As these ÃÛ¶¹ÊÓƵ Funds pursue an active management style, each Fund's performance can deviate substantially from that of its reference index. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.

Features

Product category
Equity
Asia
Product domicile
Luxembourg
Portfolio management
ÃÛ¶¹ÊÓƵ Asset Management (Hong Kong) Ltd., Hong Kong
Fund management
ÃÛ¶¹ÊÓƵ Fund Management (Luxembourg) S.A., Luxembourg
Custodian bank
ÃÛ¶¹ÊÓƵ Europe SE, Luxembourg Branch
Representative for products established under foreign law
ÃÛ¶¹ÊÓƵ Fund Management (Switzerland) AG
Day of inception
March 10, 2020
Currency of account
USD
Close of financial year
November 30
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Flat fee
1.13% p.a.
Management fee
0.90% p.a.
Total expense ratio (TER)
1.14% p.a.
Minimum investment
n.a.
Reference Index / Benchmark
MSCI China 10/40 (net div. reinv.)
Cut-Off Time
13:00h (CET)
Securities no.
50268972
ISIN
LU2059874102
Bloomberg Ticker
UBCOUIA LX

Performance and Prices

Percentage growth

as of April 3, 2024
Cumulative
USD(%) CHF(%) EUR(%)
YTD -4.61 2.66 -2.64
1M
3M
6M
1Y
2Y -14.07 -21.83 -16.98
3Y
5Y
ø p.a.5Y -9.05 -10.76 -9.10

Current data

Net asset value 03.04.2024 USD 64.92
High - last 12 months 18.04.2023 USD 81.59
Low - last 12 months 22.01.2024 USD 59.92
Assets of the unit class in mn 03.04.2024 USD 3.58
Total product assets in mn 03.04.2024 USD 3,116.34
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 29.02.2024 34.16% n.a.
Sharpe Ratio 29.02.2024 -0.57 n.a.
Risk Free Rate 31.03.2024 4.15% 2.15%

Structures

By detailed securities (in %, as of February 29, 2024)*

 
 
 
1 NetEase Inc 10.08
2 Kweichow Moutai Co Ltd 9.69
3 Tencent Holdings Ltd 9.30
4 Alibaba Group Holding Ltd 5.43
5 China Merchants Bank Co Ltd 4.90
6 CSPC Pharmaceutical Group Ltd 4.82
7 AIA Group Ltd 4.82
8 Far East Horizon Ltd 3.97
9 China Resources Land Ltd 3.15
10 Anhui Gujing Distillery Co Ltd 3.00
11 Meituan 2.82
12 Ping An Insurance Group Co of China Ltd 2.71
13 Shenzhen International Holdings Ltd 2.62
14 SSY Group Ltd 2.40
15 TAL Education Group 2.29
16 Hong Kong Exchanges & Clearing Ltd 2.09
17 Chinasoft International Ltd 1.88
18 China Overseas Land & Investment Ltd 1.72
19 PDD Holdings Inc 1.66
20 China Mobile Ltd 1.54
21 Yihai International Holding Ltd 1.51
22 Kanzhun Ltd 1.32
23 Longfor Group Holdings Ltd 1.27
24 Hansoh Pharmaceutical Group Co Ltd 1.19
25 New Oriental Education & Technology Group Inc 1.01
26 China Jinmao Holdings Group Ltd 0.99
27 Industrial & Commercial Bank of China Ltd 0.99
28 Anhui Conch Cement Co Ltd 0.94
29 Livzon Pharmaceutical Group Inc 0.81
30 China Vanke Co Ltd 0.71
31 WuXi XDC Cayman Inc 0.64
32 Kingsoft Corp Ltd 0.56
33 Wuxi Biologics Cayman Inc 0.53
34 China Everbright Ltd 0.40
35 Precision Tsugami China Corp Ltd 0.39
36 Alibaba Health Information Technology Ltd 0.28
37 Onewo Inc 0.28
38 Hainan Meilan International Airport Co Ltd 0.26
39 China Dongxiang Group Co Ltd 0.21
40 Peijia Medical Ltd 0.18
41 Dawnrays Pharmaceutical Holdings Ltd 0.17
42 Sun King Technology Group Ltd 0.17
43 Shenzhen Investment Ltd 0.17
44 Chanjet Information Technology Co Ltd 0.15
45 Vobile Group Ltd 0.14
46 Country Garden Services Holdings Co Ltd 0.12
47 Tong Ren Tang Technologies Co Ltd 0.12
48 Shanghai Junshi Biosciences Co Ltd 0.12
49 Cheerwin Group Ltd 0.10
50 Abbisko Cayman Ltd 0.08
51 MicroTech Medical Hangzhou Co Ltd 0.07
52 Horizon Construction Development Ltd 0.06
53 Wenzhou Kangning Hospital Co Ltd 0.04
54 Brii Biosciences Ltd 0.03
55 Guotai Junan International Holdings Ltd 0.02
56 Overseas Chinese Town Asia Holdings Ltd 0.02
57 Broncus Holding Corp 0.01
58 Jupai Holdings Ltd 0.01
59 Hua Han Health Industry Holdings Ltd 0.00

Fees

Flat fee
1.1300%
Management fee p.a.
0.9000%

Distributions

No distributions. Continuous reinvestment of income.

Authorisations

Country of distribution
Representative / Information
Finland
ÃÛ¶¹ÊÓƵ AG, Stockholm
Luxembourg
ÃÛ¶¹ÊÓƵ Fund Services (Luxembourg) S.A.
Switzerland
ÃÛ¶¹ÊÓƵ Fund Management (Switzerland) AG

Literature

Brochures
Document type
Document Language
Fact Sheet
Video
Fact Sheet - Equity
Fact Sheet - Asia
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Statutes / Management regulations
ESG Disclosure
SFDR Pre-Contractual Annex
Swiss Climate Scores Report
ASIP ESG Report
Annual and semi-annual report (accounting on November 30)
Document type
Document Language
Annual report
SFDR Periodic Report Annex
Semi-annual report